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Availabla online 10 April 2015Abstract Aging is associated with increased inflammation and reduced hippocampal neurogenesis, which may in turn
contribute to cognitive impairment. Taurine is a free amino acid found in numerous diets, with anti-inflammatory properties.
Although abundant in the young brain, the decrease in taurine concentration with age may underlie reduced neurogenesis.
Here, we assessed the effect of taurine on hippocampal neurogenesis in middle-aged mice. We found that taurine increased
cell proliferation in the dentate gyrus through the activation of quiescent stem cells, resulting in increased number of stem
cells and intermediate neural progenitors. Taurine had a direct effect on stem/progenitor cells proliferation, as observed in
vitro, and also reduced activated microglia. Furthermore, taurine increased the survival of newborn neurons, resulting in a net
increase in adult neurogenesis. Together, these results show that taurine increases several steps of adult neurogenesis and
support a beneficial role of taurine on hippocampal neurogenesis in the context of brain aging.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Introduction
Neurogenesis persists during adulthood in the dentate gyrus
(DG) of the hippocampus in most mammals (Altman & Das,
1965). Adult neural stem cells reside in the subgranular zone
of the DG, where they give rise to intermediate progenitor
cells. These progenitors proliferate rapidly to give rise to
neurons, whichmigrate into the granule cell layer (Kronenberg
et al., 2003). With their increased plasticity (Schmidt-Hieber
et al., 2004), new neurons enhance synaptic plasticity in the
hippocampus and participate to the mechanisms of learning⁎ Corresponding author.
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(http://creativecommons.org/licenses/by/4.0/).and memory as well as mood control (Kheirbek et al., 2012).
The age-dependent reduction in adult neurogenesis (Gebara
et al., 2013; Kuhn et al., 1996; Encinas & Sierra, 2012) is
associated with decreased learning performances (Gil-Mohapel
et al., 2013), which can be restored by increasing adult
neurogenesis with voluntary exercise (van Praag et al., 2005).
Thus, manipulations aimed at increasing adult neurogenesis
represent a promising approach for alleviating disease- or
age-related cognitive impairment (Bolognin et al., 2014) as
well as mood disorders (Drew & Hen, 2007). In this context,
nutritional supplements acting on adult neurogenesis have
been proposed as a beneficial approach to prevent or reduce
age-related cognitive loss (van Praag et al., 2007).
Taurine is a free sulfur amino acid that is not incorporated
in proteins. It is synthesized from methionine and cysteine by
the rate-limiting enzyme cysteinesulfinic acid decarboxylase
(CSD) that is found in the liver, the kidney and the brain,is is an open access article under the CC BY license
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the liver, CSD activity is increased by protein-rich diet (Bella
et al., 1999) whereas in the brain, glutamate increases CSD
activity (Wu et al., 1998). Taurine is also found in high
concentrations in numerous diets such as meat and seafood
(Huxtable, 1992) and crosses the blood brain barrier using a
specific beta amino acid transporter TAUT (TAUrine Trans-
porter (Benrabh et al., 1995)). Taurine is 3–4 times more
abundant in the developing than in the mature brain (Miller
et al., 2000) and its concentration decreases with aging
(Banay-Schwartz et al., 1989), suggesting that taurine plays a
role during brain development. Consistent with this, dietary
taurine deficiency during gestation leads to impaired devel-
opment of the cerebellum and the visual cortex of newborn
cats (Sturman et al., 1985). Intriguingly, taurine also seems to
play a role in the adult and aging brain: Chronic administration
of taurine in aged mice (El Idrissi, 2008; Neuwirth et al., 2013)
or in a mouse model of Alzheimer's disease (Kim et al., 2014)
increases hippocampus-dependent learning and retention and
reduces anxiety and depression (Chen et al., 2004). The
mechanisms by which taurine increases learning performances
are unclear, but recent work showed that taurine increases
the proliferation of adult neural stem/progenitor cells from
the subventricular zone in vitro (Ramos-Mandujano et al.,
2014; Hernandez-Benitez et al., 2012), suggesting that the
effect of taurine may be mediated by an increase in adult
neurogenesis. However, these studies did not address whether
taurine increased net hippocampal neurogenesis in vivo.
Here, we directly assessed the effect of taurine on the
age-related decline of adult hippocampal neurogenesis. To
this aim, we tested the effect of taurine injections on
10-month-old mice, an age at which adult neurogenesis has
reached its minimal activity (Kuhn et al., 1996; Gil-Mohapel
et al., 2013). Using the incorporation of the proliferation
marker 5-bromo-2-deoxyuridine (BrdU), combined with the
genetic and immunohistochemical identification of adult
hippocampal stem cells, intermediate progenitors, newborn
mature and immature neurons, we examined the effect of
taurine on several steps of the formation of new neurons in
the aging hippocampus.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guidance for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
experimental protocols were approved by the Swiss animal
experimentation authorities (Service de la consommation et
des affaires vétérinaires, Chemin des Boveresses 155, 1066
Epalinges, Switzerland). Every effort was made to minimize
the number of animals used and their suffering.
Animals and taurine administration
Animals used for the study were male mice of 2, 4, 6, 8 and
10 months of age at the beginning of the experiments. C57Bl/6j
mice were purchased from Janvier (le Genest Saint Isle,
France), nestin-GFP mice were a kind gift from the laboratory
of K. Mori (PRESTO, Kyoto, Japan) (Yamaguchi et al., 2000).These mice express the green fluorescent protein (GFP) under
the stem cell-specific promoter nestin. All animals were housed
in a 12 h light/12 h dark cycle with free access to food and
water and controlled temperature (22 °C) conditions. Taurine
was prepared fresh every day and diluted in water containing
0.9% NaCl. 10-month-old mice were injected intraperitoneally
every day for 40 consecutive days either with 0.2 ml of taurine
(265 mg/kg, Sigma-Aldrich) or with 0.2 ml of vehicle (0.9% NaCl
in water) for control animals.
BrdU administration
Mice were injected intraperitoneally with 5-bromo-2-
deoxyuridine (Sigma-Aldrich, Buchs, Switzerland) at a con-
centration of 100 mg/kg in saline, 3 times per day at 2-h
intervals, for 3 days. For proliferation studies, taurine was
injected for 40 days and BrdU injection started 24 h after the
last taurine injection. Mice were then sacrificed 24 h after the
last BrdU injection. For survival studies, BrdU was injected for
3 days and 24 h after the last BrdU injection, taurine was
injected for 40 days. 24 h after the last taurine injection,
mice were sacrificed and analyzed (Chen et al., 2004).
Tissue collection and preparation
At the end of the experiment, mice received a lethal dose of
pentobarbital (10 ml/kg, Sigma-Aldrich, Buchs, Switzerland)
and were perfusion-fixedwith 50 ml of 0.9% saline followed by
100 ml of 4% paraformaldehyde (Sigma-Aldrich, Switzerland)
dissolved in phosphate buffer saline (PBS 0.1 M, pH 7.4).
Brains were then collected, postfixed overnight at 4 °C,
cryoprotected 24 h in 30% sucrose and rapidly frozen. Coronal
frozen sections of a thickness of 40 μm were cut with a
microtome-cryostat (Leica MC 3050S) and slices were kept in
cryoprotectant (30% ethylene glycol and 25% glycerin in 1×
PBS) at −20 °C until processed for immunostaining.
Immunohistochemistry
Immunochemistry was performed as previously described
(Gebara et al., 2013). Briefly, sections were washed 3 times
in PBS 0.1 M. BrdU detection required formic acid pretreat-
ment (formamide 50% in 2× SSC buffer; 2× SSC is 0.3 M NaCl
and 0.03 M sodium citrate, pH 7.0) at 65 °C for 2 h followed
by DNA denaturation for 30 min in 2 M HCl for 30 min at
37 °C and rinsed in 0.1 M borate buffer pH 8.5 for 10 min.
Then, slices were incubated in blocking solution containing
0.3% Triton-X100 and 15% normal serum normal goat serum
(Gibco, 16210-064) or normal donkey serum (Sigma Aldrich,
D-9663), depending on the secondary antibody in PBS 0.1 M.
Slices were then incubated 40 h at 4 °C with the following
primary antibodies:mousemonoclonal anti-BrdU (48 h, 1:250,
Chemicon International, Dietikon, Switzerland), goat anti-DCX
(1:500, Santa Cruz Biotechnology, sc-8066), rabbit anti-Ki-67
(48 h, 1:200, Abcam, ab15580), rabbit anti-Tbr2 (1:200,
Abcam, ab23345), goat anti-Iba1 (1:200, Abcam, ab5076),
mouse anti-MHC-II (1:200, Abcam, ab23990) rabbit anti-GFAP
(1:500, Invitrogen, 180063) mouse anti-Neu-N (Chemicon
International 1:1000). The sections were then incubated for
2 h in either of the secondary antibodies: goat anti-mouse
Alexa-594 (1:250, Invitrogen), goat anti-mouse Alexa-660
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donkey anti-goat Alexa-555 (1:250, Invitrogen). After immu-
nostaining, slices were incubated for 1 min into 4,6 diamidino-
2-phenylindole (1:1000, DAPI) to reveal nuclei.
Cell culture
Adult neural progenitor cells (NPCs) were a kind gift from
the laboratory of Fred Gage (Salk Institute, San Diego, USA).
They were isolated from the DG of adult Fisher 344 rats and
cultured as previously described (Palmer et al., 1997) at a
density of 20,000 cells per well. Three wells per condition
were used and experiments were replicated 3 times.
Twenty-four hours after plating, the medium was supple-
mented with 10 mM taurine (Sigma-Aldrich) every day, for
7 days (Hernandez-Benitez et al., 2012). On the eighth day,
medium was supplemented with 5 μM BrdU for 30 min then
washed and fixed with 4% paraformaldehyde for 20 min,
briefly washed, immunostained for BrdU and mounted.
Image analysis
All images were acquired using a Zeiss confocal microscope
(Zeiss LSM 710 Quasar Carl Zeiss, Oberkochen, Germany).
The total numbers of immunoreactive cells throughout the
entire granule cell layer were estimated using stereological
sampling, as previously described (Thuret et al., 2009),
between −1.3 and −2.9 mm from the Bregma. However, no
guard zones were used, which may lead to possible bias in
the counting of cells at the edge of each section, spread
across control and taurine groups. For each animal, a 1-in-6
series of sections was stained with the nucleus marker DAPI
and used to measure the volume of the granule cell layer.
The granule cell area was traced using Axiovision (Zeiss,
Germany) software and the granule cell volume was
determined by multiplying the traced granule cell layer
area by the thickness of the corresponding section and the
distance between the sections sampled (240 μm). For all the
mice analyzed in this study, no difference was found
between taurine-treated and control animals in the volume
of the granule cell layer. All cells were counted blind
with regard to the mouse status. The total number of
immunolabeled cells were counted in the entire thickness of
the sections in a 1-in-6 series of section (240 μm apart), for a
total of 8 sections, with a 40× objective. The number of cells
was then related to granule cell layer sectional volume and
multiplied by the reference volume to estimate the total
number of immunolabeled cells (Gebara et al., 2013; Thuret
et al., 2009). Cells expressing BrdU, Ki-67, DCX or Tbr2 were
counted in the granule cell layer and the subgranular zone,
whereas cells expressing Iba-1 (microglia), MHC II and cells
expressing GFAP with a prototypical stellar astrocyte
morphology were counted in the whole dentate gyrus, as
these cell types are scarce in the granule cell layer. BrdU
colocalization with the neuronal marker NeuN was analyzed
on confocal microscope image stacks and was confirmed on
single optical sections, for 52–70 cells per animal. The
proportion of double-labeled cells was then obtained for
each animal and then averaged for each group (Gebara et
al., 2013). 3D reconstructions were performed using Imaris
7.6.1 (Bitplane, South Windsor, CT, USA).For in vitro cell quantification, images were acquired
using confocal microscopy. The number of BrdU labeled NPCs
was counted in 4 selected fields, systematically placed in
the same position relative to the coverslips' edges. The
number of BrdU labeled NPCs was reported to the total
number of NPCs in each selected field to obtain a percentage
of proliferation in each condition.
Statistical analysis
Hypothesis testing was two-tailed. All analyses were per-
formed using JMP10 software. First, Shapiro–Wilk tests were
performed on each group of data to test for distribution
normality. For normal distribution, the equality of variances
of the groups was tested and a bilateral Student t-test was
performed. For non-normal distribution, we performed the
Wilcoxon test. Data are presented as mean ± SEM.
Results
Taurine increased stem cell proliferation in the DG
We first examined the effect of taurine on cell proliferation in
the DG. Ten-month-old nestin-GFP mice were injected daily
for 40 days with either taurine (i.p. 265 mg/kg), or with the
same volume (0.2 ml) of vehicle (0.9% NaCl) as control. This
regimen has previously been shown to reduce inflammation
(Yamaguchi et al., 2000) and the inflammation-induced
inhibition of adult hippocampal neurogenesis (Palmer et al.,
1997). Nestin-GFP mice express the GFP reporter under the
control of the stem cell-specific nestin promoter thereby
enabling the identification of adult neural stem cells (Kim et
al., 2014). Twenty-four hours after the last taurine
injection, all mice received 3 injections per day at 2-h
intervals for 3 days of the synthetic thymidine analog
5-bromo-2-deoxyuridine (BrdU, i.p., 100 mg/kg) and were
sacrificed 24 h after the last BrdU injection (Fig. 1A). Mice
were perfused, the brains collected, sectioned and immuno-
stained for BrdU and the endogenous proliferation marker
Ki-67. The total number of immunoreactive cells was counted
in the granule cell layer (GCL) and the subgranular zone of
the DG. Taurine significantly increased the number of
BrdU-expressing cells (Fig. 1B–C, bilateral Student's t-test
p b 0.001) and the number of Ki-67-expressing cells (Fig. 1D–E,
bilateral Student's t-test p b 0.001). To test whether the
increased number of BrdU- or Ki-67-expressing cells could be
caused by a change in hippocampal volume upon taurine
treatment, we measured the volume of the GCL of all mice.
There was no difference between groups (controls: 0.17 ±
0.08 mm3; Taurine: 0.17 ± 0.07 mm3, n = 5, bilateral
Student's t-test p = 0.26). These results indicate that taurine
increased cell proliferation in the subgranular zone of the DG.
We next identified the cell types contributing to the
taurine-induced increase in cell proliferation, using immuno-
histochemistry and morphology. Two main types of prolifer-
ative cells co-exist in the subgranular zone: The radial glia-like
(RGL), nestin-expressing stem cells, readily identifiable by
their morphology consisting of a nucleus located in the
subgranular zone, a large process extending through the GCL
and branching into the proximal part of the molecular layer;
and the intermediate neural progenitor cells, with short
Figure 1 Taurine increased cell proliferation in the DG. (A) Experimental timeline: Mice were injected with taurine or vehicle
(NaCl) for 40 days, followed immediately by 3 BrdU (5-bromo-2-deoxyuridine) injections per day for 3 days. Twenty-four hours after
the last injection, brain slices were processed for histology. (B) Histogram of the total number of BrdU-immunopositive cells in the
granule cell layer of the DG. (C) Confocal maximal projection micrographs of hippocampal sections immunostained for BrdU. Inset:
Higher magnification confocal micrograph of a BrdU-positive cell. (D) Histogram of the total number of Ki-67-expressing cells in the
GCL of the DG. (E) Confocal maximal projection micrographs of hippocampal sections immunostained for Ki-67. Inset: Higher
magnification confocal micrograph of a Ki-67 expressing cell. Blue: Dapi staining. Animals, n = 5 per group. Scale bars: 100 μm, insets
10 μm, bilateral Student's t-test ***p b 0.001. Each value represents the mean ± SEM.
372 E. Gebara et al.processes extending into subgranular zone/GCL area. Both
cell types express the T-box brain gene-2 transcription factor
(Tbr2 (Hodge et al., 2008)), but they can be differentiated by
their distinct morphology. Taurine increased the number of
RGL stem cells in the subgranular zone of the DG as compared
to NaCl (Fig. 2A–B, bilateral Student's t-test p b 0.001). To
test whether taurine increased the division of RGL stem cells,
mitigated the age-related reduction in RGL stem cells number
or both, we measured RGL stem cell number at 2, 4, 6, 8 and
10 months of age. Consistent with previous reports (Encinas et
al., 2011; Walter et al., 2011; Bonaguidi et al., 2011), RGL
stem cells' number decreased over time and reached its
minima at 8 months (Fig. 2C). There was no significant
difference between 8 months and NaCl-treated animals
(i.e. 11.5 months, p = 0.42). In stark contrast, taurine treat-
ment on 10 month-old mice restored the number of RGL stem
cells to values found in 2-months-old mice (bilateral Student's
t-test p = 0.22). This effect may be mediated by the prolifer-
ation of RGL stem cells, since taurine increased the percentage
of BrdU-expressing RGL stem cells (Fig. 2D-E, bilateral Student's
t-test p b 0.05). Taurine also significantly increased the total
number of Tbr2-expressing cells (Fig. 2F–G, bilateral Student's
t-test p b 0.01), but did not increase the proportion of
Tbr2-expressing cells that incorporated BrdU (Fig. 2b H–I,bilateral Student's t-test p = 0.6). These results suggest that
taurine increased the proliferation of RGL stem cells, resulting
in an increase of both RGL stem cells and Tbr2+ progenitor cells
populations.Taurine increased the number of immature neurons
The increased number of Tbr2+ progenitors may result in
increased neuronal production.We next examined the effect of
taurine on immature new neurons, identified by the expression
of the immature neuronal marker doublecortin (DCX). Taurine
increased the total number of DCX-immunostained neuronal
soma in the subgranular zone/GCL (Fig. 3A–B, bilateral
Student's t-test p b 0.001). Furthermore, upon taurine treat-
ment, immature neurons displayed increased proportion of
dendritic branches extending into the molecular layer, sug-
gesting increased maturation (Fig. 3C–D, Bilateral Student's
t-test for 125 μm from the GCL: p b 0.05). To further
investigate the effect of taurine on new neurons' maturation,
we quantified the three categories of DCX-expressing cells (Seri
et al., 2004): cells without process, known to be the most
immature subtype with the highest proliferative activity, cells
with horizontal processes and cells with a radial process,
Figure 2 Taurine increased the proliferation of RGL stem cells. (A) Quantification of the total number of nestin-GFP stem cells with
RGL (radial glia-like) morphology in the subgranular zone of the DG. (B) Confocal maximal projection micrographs of hippocampal
sections of nestin-GFP mice. Inset: Higher magnification confocal micrograph of a GFP-expressing RGL stem cell. Scale bars: 100 μm,
inset 10 μm. (C) Time course of the total number of RGL in 2, 4, 6, 8 and 10 month old mice. (D) Histogram showing the percentage of
BrdU-immunostained RGL stem cells over the total number of RGL cells. (E) Left panel: Confocal micrograph of a hippocampal section
(maximal projection) immunostained for BrdU (red) and GFP (green). Scale bar: 10 μm. Right panel: Orthogonal projections of the
same RGL stem cell. (F) Histogram of the total number of Tbr2-expressing intermediate progenitor cells in the GCL of the DG.
(G) Confocal maximal projection micrographs of hippocampal sections immunostained for Tbr2. Inset: Higher magnification confocal
micrograph of a Tbr2-expressing cell. Blue: Dapi staining. Scale bars: 100 μm, inset 10 μm. (H) Histogram of the percentage of BrdU+
Tbr2+ cells over the total number of Tbr2+ cells. (I) Left panel: Confocal micrograph of a hippocampal section (maximal projection)
immunostained for Tbr2 (red) and BrdU (white). Scale bar: 10 μm. Right panel: Orthogonal projections of a BrdU+
Tbr2+-immunolabeled cell. Animals, n = 5 per group. Bilateral Student's t-test N.S.: p N 0.05 *p b 0.05 **p b 0.01 ***p b 0.001.
Each value represents the mean ± SEM.
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significantly increased the proportion of DCX-expressing cells
with a process (Student's t-test: p b 0.001), an effect that wasalmost entirely due to an increase in cells with a radial process
(Fig. 3F, Student's t-test: p b 0.001). All together, these results
suggest that taurine increased the number of new, immature
Figure 3 Taurine increased the number of immature neurons. (A) Histogram of the number of DCX+ cells in the GCL of the DG.
(B) Confocal maximal projection micrographs of hippocampal sections immunostained for DCX. Inset: Higher magnification confocal
micrograph of a DCX-positive cell. Dapi staining. Scale bars: 100 μm, insets 10 μm. (C) Confocal micrograph of DCX+ cells, extending
dendrites in the molecular layer. Scale bar: 100 μm. (D) The number of dendritic branches crossing each white bar (shown in C) was
counted and normalized to the value measured at 0 μm, to account for the increased number of cells. (E) Schematic illustration of the
three subtypes of DCX expressing cells, based on the presence and orientation of their processes. (F) Histogram showing the
proportion of DCX expressing cells without process, with a radial or a horizontal process in NaCl and taurine-treated animals. Animals,
n = 5 per group. Bilateral Student's t-test N.S.: p N 0.05 *p b 0.05 ***p b 0.001. Each value represents the mean ± SEM.
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morphological characteristics.
Taurine increased neurogenesis
We next examined the effect of taurine on the fate of
newly-divided cells. Ten-month-old C57Bl/6 mice were
injected with BrdU for 3 days (i.p., 100 mg/kg, 3 injections
per day at 2-h intervals) and 24 h after the last injection,
were treated with daily injections of taurine for 40 days.
Owing to the short half-life of BrdU (11 min (Taupin, 2007)),this protocol ensures that BrdU is not incorporated into cells
after 24 h (Sultan et al., 2013a). One day after the last taurine
injection, mice were sacrificed, the brains removed, sliced
and immunostained against BrdU and the mature neuronal
marker Neu-N (Fig. 4A). The number of BrdU-labeled cells was
significantly increased by 66% in taurine-injected animals
(Fig. 4B bilateral Student's t-test p b 0.05). BrdU can be
retained in daughter cells after several divisions. Since taurine
increased proliferation by 22% (Fig. 1B), the effect observed
here is consistent with an increase in both proliferation and
survival of the new cells.
375Taurine increases neurogenesis in aging miceWe then assessed the neuronal differentiation of newborn
cells into neuronal lineage by measuring the proportion of
BrdU-labeled cells that also expressed NeuN (Fig. 4C–E). In
taurine-treated mice, neurons accounted for 85 ± 8% of the
surviving BrdU-positive cells as compared to 60.5 ± 10% in
NaCl mice. This difference was however not significant
(Wilcoxon test, p = 0.07, Fig. 4C), indicating that taurine did
not significantly increase neuronal differentiation. Nonethe-
less, when the number of surviving cells was multiplied by
the fraction of cells that differentiated into neurons,
taurine-treated mice had about 128% more newly-formed
neurons than vehicle-treated mice (Fig. 4D, bilateral
Student's t-test p b 0.01). Thus taurine increased net adult
neurogenesis.Taurine decreased microglia
Taurine is known to have anti-inflammatory properties
(Menzie et al., 2013; Kim & Cha, 2014) and we recently
found that the number of microglia in the dentate gyrus isFigure 4 Taurine increased the survival of new-born neurons. (A)
day for 3 days. 24 h after the last BrdU injection, mice were injecte
24 h after the last taurine injection, mice were sacrificed and their
number of BrdU-expressing cells. (C) Histogram showing the percent
cells. Wilcoxon test N.S.: p = 0.07 (D) Histogram of the total numb
micrograph of a hippocampal section immunostained for BrdU (red) a
of BrdU-NeuN expressing cells. Scale bar: 100 μm, inset 10 μm. For t
group and 52–70 cells per animal. Bilateral Student's t-test: *p b 0.0inversely correlated with the proliferation of stem/progenitor
cells in aged mice (Gebara et al., 2013). To test the effect of
taurine on microglia in the DG, we examined microglia using
immunostaining against the microglia-specific marker Iba1
(Fig. 5). Taurine significantly decreased the total number of
Iba1-expressing microglia in the DG (Fig. 5A–B, bilateral
Student's t-test p b 0.001), but did not affect the number of
GFAP-immunolabeled astrocytes (Supplementary Fig. 1, bilat-
eral Student's t-test p = 0.57), indicating that the effect of
taurine was specific for microglia. Brain inflammation results
inmorphological changes ofmicroglia upon activation: Resting
microglia (stage I) have rod-shaped cell bodies with fine,
ramified processes whereas activated microglia (stage II) have
elongated cell bodies with long thick processes (Fig. 5C)
(Mathieu et al., 2010; Preissler et al., 2015; Streit et al.,
1999). We therefore examined the morphology of microglia in
taurine-treated and control animals. Taurine decreased the
soma area (Fig. 5D, bilateral Student's t-test p b 0.001),
increased the territory projection area (Fig. 5E, bilateral
Student's t-test p b 0.001) and the number of branches
(Fig. 5F, bilateral Student's t-test p b 0.001) of microglia.Experimental timeline: Mice were injected with BrdU 3 times a
d with taurine or NaCl (n = 5 mice per group) daily for 40 days.
brains processed for histology (B) Histogram showing the total
age of BrdU+ NeuN+ new neurons over the total number of BrdU+
er of new, BrdU+ newborn neurons. (E) Upper panel: confocal
nd NeuN (green). Lower panel. Higher magnification micrograph
he NeuN–BrdU co-localization study, we analyzed 3 animals per
5, **p b 0.01. Each value represents the mean ± SEM.
376 E. Gebara et al.These morphological modifications are consistent with a
decreased activation state of microglia upon taurine treat-
ment. Consistently, activated microglial cells accounted for
8.2 ± 0.75% of the total number ofmicroglia in taurine-treated
animals and for 37.8 ± 1.8% in NaCl-treated animals (bilateral
Student's t-test p b 0.001). Finally, the expression of theFigure 5 Taurine decreased microglia number and markers of m
Iba1-expressing cells in the DG. (B) Confocal micrographs (maxima
Inset: Higher magnification confocal micrograph of an Iba1-immuno
microglia in activated (left) and resting state (right). (D) Drawing (up
microglia. (E) Drawing and histogram showing the territory area o
branches per microglia. (G) Histogram showing the total number of
(maximal projections) of hippocampal sections immunostained for M
100 μm, inset 10 μm. Bilateral Student's t-test ***p b 0.001. Each vaactivated microglia marker MHC-II (Frank et al., 2006) was
significantly reduced in the DG of taurine-treated mice
(Fig. 5G–H, bilateral Student's t-test p b 0.001). Thus,
consistently with previous studies (Menzie et al., 2013; Kim &
Cha, 2014; Kim & Kim, 2005; Chan et al., 2014) these results
suggest that taurine decreased microglia number.icroglia activation. (A) Histogram showing the total number of
l projections) of hippocampal sections immunostained for Iba1.
labeled cell. (C) Confocal micrographs and 3D reconstruction of
per panel) and histogram (lower panel) showing the soma area of
f microglia. (F) Drawing and histogram showing the number of
MHC-II-expressing microglia in the DG. (H) Confocal micrographs
HC-II. Blue: Dapi staining. Animals: n = 5 per group. Scale bars:
lue represents the mean ± SEM.
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progenitor cells in vitro
Finally, we examinedwhether taurinemay have a direct effect
on stem/progenitor cells. For this, we performed in vitro
experiments on purified adult hippocampal stem/progenitor
cells (NPCs). 20,000 NPCs per well were plated and treated
everyday with either 10 mM taurine or the equivalent volume
of PBS 0.1 M for half an hour. After 7 days, the medium was
supplemented with 5 μM BrdU for 30 min then washed
and immediately fixed and immunostained for BrdU
(Hernandez-Benitez et al., 2012). Taurine increased the
proportion of NPCs that incorporated BrdU (Fig. 6A–B,
Student's t-test, p b 0.01), indicating that taurine directly
increased the proliferation of NPCs.
Discussion
In the present study, we tested the effect of chronic
administration of taurine on hippocampal neurogenesis in
aging mice. We found that taurine increased cell proliferation
in the DG. More specifically, RGL stem cells showed enhanced
proliferation that resulted in an increase in the number of RGL
stem cells, Tbr2+ intermediate progenitors and DCX+ imma-
ture neurons. Moreover, taurine increased the survival of new
neurons, resulting in a net increase in adult neurogenesis.
Taurine also a reduced microglia number, morphological
parameters associated with activation, MHC-II expression
and increased stem/progenitor cell proliferation in vitro.
Together, these results indicate that, in the aging brain,
taurine increases the production of new neurons by stimulat-
ing several steps of adult neurogenesis and plays a role in
microglia function.
Taurine is known to be involved in variety of cellular
processes, including calcium homeostasis (El Idrissi, 2008; Wu
et al., 2005; Foos & Wu, 2002), protection from glutamate
excitotoxicity and apoptosis (Foos & Wu, 2002; Leon et al.,
2009), inflammation (Kim & Cha, 2014), oxidative stress
(Menzie et al., 2013), and epilepsy (El Idrissi et al., 2003), all
of which contribute to the regulation of adult neurogenesis.
However, since there is currently no known taurine receptor,
its role as an osmolyte is believed to participate to these
processes. Our results suggest that taurine can regulate adult
neurogenesis both through an indirect effect on microglia and
a direct effect on stem/progenitor cells.Figure 6 Taurine increased the proliferation of adult hippocampal
percentage of NPCs immunostained for BrdU over the total number o
panel) or taurine (right panel). n = 3 culture wells per group. *p b 0The indirect effect of taurine on adult neurogenesis may
be mediated by its anti-inflammatory properties: taurine
reduces the production of inflammatory cytokines such as
TNFα or IL-1β (Kim & Cha, 2014) and its derivative,
taurine-chloramine, reduces the activation of NFkb in several
models of inflammation (Kim & Kim, 2005). In the brain,
taurine administration reduces cell damage and cytokines
expression after traumatic brain injury (Chan et al., 2014) and
mitigates lipopolysaccharide-induced inflammation and mi-
croglia activation (Menzie et al., 2013). In physiological
conditions, brain aging is accompanied by increased expres-
sion of genes involved in cellular stress and inflammation
(Sturman et al., 1985) and increased microglia proliferation
and activity (Kohman, 2012). In turn, this increased inflam-
mation negatively correlates with hippocampal RGL stem cells
proliferation (Gebara et al., 2013). Thus, the increased
inflammation in the aging brain inhibits hippocampal
neurogenesis and conversely, anti-inflammatory treatments
that reduce microglia activation, increase adult neurogenesis
(Gebara et al., 2013; Sultan et al., 2013b). Consistent with
these observations, taurine partially restores cell proliferation
in the DG after lipopolysaccharide-induced inflammation
(Menzie et al., 2013). Altogether, these results suggest that
the effect of taurine on adult neurogenesis that we observed
in the aging brain may be, at least partially, mediated by a
reduction in microglia activation. Although we did not directly
measure levels of inflammatory cytokines in this study, this
possibility is consistent with our observations of decreased
microglia number, reduced morphological markers that are
normally associated with activation and reduced MHC-II
expression upon taurine treatment.
In addition to its indirect effect, taurine directly
increased the proliferation of purified adult hippocampal
stem/progenitor cells in vitro, similarly to what was
previously observed on subventricular zone progenitors
(Ramos-Mandujano et al., 2014). The antioxidant (Schaffer
et al., 2009) and antiapoptotic properties of taurine (Taupin,
2007; Sultan et al., 2013a), can potentially contribute to
the increased proliferation and survival rate of the highly
proliferative and metabolically active neural stem cells and
new neurons. Of particular interest, taurine has recently been
shown to interact with the polyamine site of the NMDA
receptor and modulate the activity of the NMDA receptor
(Chan et al., 2014). NMDA receptors are expressed by RGL
stem cells and regulate their activity (Muth-Kohne et al.,
2010), as demonstrated by the increased proliferation inducedstem/progenitor cells (NPCs) in vitro. (A) Histogram showing the
f NPCs. (B) Confocal micrographs of NPCs treated with NaCl (left
.05. Each value represents the mean ± SEM. Scale bar: 20 μm.
378 E. Gebara et al.by the NMDA receptor antagonists memantine or MK-801
(Namba et al., 2009), and the co-agonist D-serine (Sultan et
al., 2013a). NMDA receptors are also expressed on immature
adult-born hippocampal neurons and are required for the
survival of these cells (Tashiro et al., 2006). Thus, by directly
modulating NMDA receptor activity on RGL stem cells and on
immature neurons, taurine may increase the proliferation
of the former and the survival of the latter and thereby
contribute to the increased neurogenesis we observed.
Endogenous taurine is released by astrocytes (Choe et al.,
2012) and may contribute to the regulation of adult
neurogenesis by the microenvironment. With age, the dysreg-
ulation of the neurogenic niche (Bernal & Peterson, 2011;
Katsimpardi et al., 2014) may involve a reduction of astrocytic
function, leading to reduced taurine production, thereby
causing age-related impaired neurogenesis.
Reduced adult neurogenesis contributes to age-related
cognitive impairment and several therapeutic approaches for
stroke or neurodegenerative disorders target adult neuro-
genesis. The renewal of stem cells in the adult brain being
limited (Calzolari et al., 2015), approaches that increase the
stem cell poolmay yield amore promising outcome for restoring
neurogenesis in the aged brain, than targeting later stages of
the process. In light of our results, the potent activating effect
of taurine on RGL stem cells may underlie its beneficial
cognitive effects and may represent a promising approach for
the treatment of age-related reduction in adult neurogenesis
and cognition.
Supplementary data to this article can be found online at
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